News

FDA Approves Baxdrostat (Baxfendy) as First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

FDA · hypertension · 7 min

Datroway Priority Review Fuels Hope for Metastatic Triple-Negative Breast Cancer Patients

FDA · breast cancer · 7 min

SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma AB

FDA · 6 min

Italy's Clinical Research Landscape: Strengths, Weaknesses, and Strategic Implications

FDA · 7 min

EMA Initiates Implementation of New EU Pharmaceutical Legislation: What Pharma Needs to Know

EMA · 8 min

Regeneron Pharma Stock Holds Steady Amid EMA Eye Drug Review and Analyst Target Adjustment

EMA · eye drug · 6 min

Teva's Once-Monthly Schizophrenia Shot Enters EMA Review, Signaling New Treatment Option

EMA · schizophrenia · 8 min

ASCO 2026: European Pharma's Quiet Showing and What AstraZeneca & Roche Must Address

7 min

ESMO 2025: Key Advances in Non-Muscle-Invasive Bladder Cancer Shape Future Oncology Strategies

oncology · 8 min

Datroway and Trodelvy Vie for First-Line TNBC Dominance Amidst Evolving Treatment Landscape

oncology · 8 min

Idorsia's C. difficile Vaccine Shows Continued Positive Clinical Progress

Clostridioides difficile infection · 7 min